EXPLORE / Growth-hormone pathways

Understand the pathway. Then the options.

Compare formulations discussed in growth-hormone care without confusing a biological mechanism with a proven result.

Explore the formulations.

4 in this topic
IGF-LR3 200mcg total per vial vial, 5 mL injectable
Growth-hormone pathways

IGF-LR3

A growth-factor analog—not the same as a GH-releasing peptide.

200mcg total per vial · 5 mL
$255/ vial · all-inclusive

Product images show the labeled vial for identification; actual pharmacy packaging may differ. Listed strengths are specifications, not dosing instructions.

CONTEXT BEFORE COMMITMENT

Are these treatments interchangeable?

No. Growth-hormone-releasing peptides and growth-factor analogs act differently. Medical history, hormone status, potential metabolic effects, and evidence for the specific use matter. A formulation being listed here does not establish that it is appropriate for you.

THE DETAILS MATTER

Good questions. Clear answers.

Are these treatments interchangeable?

No. Growth-hormone-releasing peptides and growth-factor analogs act differently. Medical history, hormone status, potential metabolic effects, and evidence for the specific use matter. A formulation being listed here does not establish that it is appropriate for you.

What is included in the listed price?

Every listed price is for one specified vial and includes the asynchronous consultation, supplies, and two-day shipping. It is not a monthly subscription price. Shipping transit begins after dispensing; clinician review and pharmacy preparation take additional time.

What does clinician-supervised mean?

A licensed clinician reviews your health history, current medications, and the reason you are seeking care. They decide whether treatment is appropriate. A catalog listing or completed consultation does not guarantee a prescription. Pharmacy and state requirements also apply.

Are these formulations FDA-approved?

The compounded formulations in this catalog are not FDA-approved. FDA does not review compounded drugs for safety, effectiveness, or quality before marketing. Several listed peptides have limited human safety data and specific FDA-identified safety concerns; see each treatment page and our clinical information page.

YOUR NEXT STEP

Less guesswork.
More guidance.

Start with a conversation about what makes sense for you.

Explore your next step

A clinician decides.
You stay informed.

Clear formulations. Transparent pricing.
No promises your health should have to rely on.